Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. (Q34272156)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

review article

1 reference

title

Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

2

Minetta C Liu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

10

Yue Wang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Leena Hilakivi-Clarke

11

object named as

Leena A Hilakivi-Clarke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Kerrie B Bouker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Zhiping Gu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Richard Y Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Yuelin Zhu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Todd C Skaar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Bianca Gomez

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Kerry O'Brien

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

language of work or name

English

0 references

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

7316-7339

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206937

20 December 2019

exact match

0 references

cites work

Estrogen receptors and long-term prognosis in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Potential role of dietary isoflavones in the prevention of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Prospective evaluation of vitamin E for hot flashes in breast cancer survivors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Calmodulin is essential for estrogen receptor interaction with its motif and activation of responsive promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Genistein: does it prevent or promote breast cancer?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Multifunctional aspects of the action of indole-3-carbinol as an antitumor agent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Molecular basis of agonism and antagonism in the oestrogen receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Serum Soluble Vascular Cell Adhesion Molecule-1: Role as a Surrogate Marker of Angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

A unified mechanism in the initiation of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Inhibition of the RelA(p65) NF-kappaB subunit by Egr-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

The inter-relationships between ovarian-independent growth, tumorigenicity, invasiveness and antioestrogen resistance in the malignant progression of human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Effect of P-glycoprotein expression on sensitivity to hormones in MCF-7 human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

The process of malignant progression in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Molecular and pharmacological aspects of antiestrogen resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Reduction of the membrane fluidity of human breast cancer cells by tamoxifen and 17 beta-estradiol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

NF-kappaB and apoptosis in mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Activation and repression of the 2-5A synthetase and p21 gene promoters by IRF-1 and IRF-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Selective activation of NF-kappa B subunits in human breast cancer: potential roles for NF-kappa B2/p52 and for Bcl-3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Ionizing radiation down-regulates p53 protein in primary Egr-1-/- mouse embryonic fibroblast cells causing enhanced resistance to apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

NF kappa B and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Structure of IRF-1 with bound DNA reveals determinants of interferon regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Tamoxifen metabolism: pharmacokinetic and in vitro study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Digitized mammography: a clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen, or placebo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Overexpression of caspase-3 restores sensitivity for drug-induced apoptosis in breast cancer cell lines with acquired drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

The role of estrogen receptors in breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Gene amplification and expression of the steroid receptor coactivator SRC3 (AIB1) in sporadic breast and endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Thoughts on tamoxifen resistant breast cancer. Are coregulators the answer or just a red herring?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

The ligand binding profiles of estrogen receptors alpha and beta are species dependent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Do estrogens always increase breast cancer risk?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Prepubertal exposure to zearalenone or genistein reduces mammary tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

A maternal diet high in n - 6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

The proto-oncogene c-myc in hematopoietic development and leukemogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Estrogen receptor variants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Pharmacokinetics, pharmacological and anti-tumour effects of the specific anti-oestrogen ICI 182780 in women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Response to a specific antioestrogen (ICI 182780) in tamoxifen-resistant breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Dual effect of parity on breast cancer risk.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Breast cancer: cause and prevention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Down-regulation of nucleophosmin/B23 mRNA delays the entry of cells into mitosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

NF-kappaB in cancer: from innocent bystander to major culprit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Vascular effects of estrogen and vitamin E therapies in postmenopausal women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Cloning of a novel receptor expressed in rat prostate and ovary

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

ER beta inhibits proliferation and invasion of breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

c-Myc in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Are the effects of tamoxifen on the serum lipid profile modified by apolipoprotein E phenotypes?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Phytoestrogen interaction with estrogen receptors in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Suppression by estrogen receptor beta of AP-1 mediated transactivation through estrogen receptor alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Retinoid-tamoxifen interaction in mammary cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Minireview: nuclear receptor coactivators--an update

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Estrogen receptor transformation in MCF-7 breast cancer cells: characterization by immunochemical and sedimentation analyses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Protein kinase inhibition by omega-3 fatty acids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Activation of the human p27(Kip1) promoter by IFNalpha 2b.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

The pathophysiological role of estrogen receptor variants in human breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Differential effects of estrogen and antiestrogen on in vitro clonogenic growth of human breast cancers in soft agar.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

EXPRESSION OF NUCLEOPHOSMIN/B23 IN NORMAL AND NEOPLASTIC COLORECTAL MUCOSA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

An isoform of the coactivator AIB1 that increases hormone and growth factor sensitivity is overexpressed in breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

The role of mitogen-activated protein (MAP) kinase in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Expression of oestrogen receptor beta (ERbeta1) protein in human breast cancer biopsies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Estrogen Replacement Therapy and Breast Cancer Survival in a Large Screening Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Mutations targeted to a predicted helix in the extreme carboxyl-terminal region of the human estrogen receptor-alpha alter its response to estradiol and 4-hydroxytamoxifen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Two-dimensional gel electrophoresis analyses identify nucleophosmin as an estrogen regulated protein associated with acquired estrogen-independence in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Vitamin E consumption and the risk of coronary disease in women.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Interferon gamma (IFNgamma ) and tumor necrosis factor alpha synergism in ME-180 cervical cancer cell apoptosis and necrosis. IFNgamma inhibits cytoprotective NF-kappa B through STAT1/IRF-1 pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Effects of tamoxifen on benign breast disease in women at high risk for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Molecular cloning of an estrogen receptor beta subtype from the goldfish, Carassius auratus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Normal breast epithelial cells induce apoptosis of breast cancer cells via Fas signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Specific phosphorylation of nucleophosmin on Thr(199) by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Comparison of transcriptional synergy of estrogen receptors alpha and beta from multiple tandem estrogen response elements

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Hepatocyte isolation stimulates formation of interferon stimulatory response element DNA-protein complexes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

A clinical trial of estrogen-replacement therapy after ischemic stroke

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Molecular effects of genistein on estrogen receptor mediated pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Three-dimensional models of estrogen receptor ligand binding domain complexes, based on related crystal structures and mutational and structure-activity relationship data.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Production of 8-hydroxy-2'-deoxguanosine in DNA by microsomal activation of tamoxifen and 4-hydroxytamoxifen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206937

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206937

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 December 2019

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14576841%20AND%20SRC:MED&resulttype=core&format=json